Summary
Subunit vaccines which target viral envelope glycoproteins offer promise for the prevention of congenital cytomegalovirus (CMV) infection. The guinea pig model of CMV infection is uniquely well suited to testing vaccines for prevention of congenital infection, since, in contrast to other animal cytomegaloviruses, the guinea pig CMV (GPCMV) crosses the placenta, producing intrauterine infection. Antibody to the CMV glycoproteins B (gB) and H (gH) appears to be important in conferring protective immunity. Unfortunately, little is known about specific GPCMV envelope glycoproteins. Sequencing of GPCMV genome fragments was therefore undertaken to test whether GPCMV encodes a gH homologue. Partial sequencing of theHind III A fragment of the GPCMV genome revealed an open reading frame of 2 169 nucleotides capable of encoding a protein of 723 amino acids. Computer matrix analyses demonstrated identity between this ORF and the gH coding sequences of other herpesviruses. The GPCMV gH ORF encodes 12 highly conserved cysteine residues, contains 9 potential N-linked glycosylation sites, and has a predicted Mr of 81.6 kDa. Northern blot hybridizations with gH-specific probes identified an abundant 5.1 kb mRNA with expression kinetics of an “early” gene. A polyclonal antiserum raised against a synthetic peptide derived from the deduced amino acid sequence of the gH ORF identified a virion-associated protein with an approximate Mr of 85-kDa, the putative GPCMV gH, in immunoblot assays.
Similar content being viewed by others
References
Adler SP, Starr SE, Plotkin SA, Hempfling SH, Buis J, Manning ML, Best AM (1995) Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. J Infect Dis 171: 26–32
Alford CA, Britt WJ (1990) Cytomegalovirus. In: Fields BN, Knipe DM (eds) Virology. Raven Press, New York, pp 1 981–2 010
Anderson RA, Liu DX, Gompels UA (1996) Definition of a human herpesvirus-6 betaherpesvirus-specific domain in glycoprotein gH that governs interaction with glycoprotein gL: substitution of human cytomegalovirus glycoproteins permits group-specific complex formation. Virology 217: 517–526
Birnstiel ML, Busslinger M, Strub K (1985) Transcription termination and 3′ end processing: the end is in site! Cell 41: 349–359
Boppana SB, Pass RF, Britt WJ, Stagno S, Alford, CA (1992) Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J 11: 93–99
Bratcher DF, Bourne N, Bravo FJ, Schleiss MR, Slaoui M, Myers MG, Bernstein DI (1995) Effect of passive antibody on congenital cytomegalovirus infection in guinea pigs. J Infect Dis 172: 944–950
Britt WJ, Vugler L, Butfiloski EJ, Stephens EB (1990) Cell surface expression of human cytomegalovirus (HCMV) gp 55–116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response. J Virol 64: 1 079–1 085
Chee MS, Bankier AT, Beck S, Bohni R, Brown CM, Cerny R, Horsnell T, Hutchinson CA, Kouzarides T, Martignetti JA, Preddie E, Satchwell SC, Tomlinson P, Weston KM, Barrell BG (1990) Analysis of the protein coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol 154: 125–169
Cranage MP, Smith GL, Bell SE, Hart H, Brown C, Bankier AT, Tomlinson P, Barrell BG, Minson TC (1988) Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type I glycoprotein H. J Virol 62: 1 416–1 422
Demmler GJ (1991) Infectious Diseases Society of America and Centers for Disease Control: summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis 13: 315–329
Faisst S, Meyer S (1992) Compilation of vertebrate-encoded transcription factors. Nucleic Acids Res 20: 3–26
Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA (1992) The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 326: 663–667
Gao M, Isom HC (1984) Characterization of the guinea pig cytomegalovirus genome by molecular cloning and physical mapping. J Virol 52: 436–447
Geballe AP, Mocarski ES (1988) Translational control of cytomegalovirus gene expression is mediated by upstream AUG codons. J Virol 62: 3 334–3 340
Gompels UA, Minson AC (1989) Antigenic properties and cellular localization of herpes simplex virus glycoprotein H synthesized in a mammalian cell expression system. J Virol 63: 4 744–4 755
Gompels UA, Carss AL, Saxby C, Hancock DC, Forrester A, Minson AC (1991) Characterization and sequence analyses of antibody-selected antigenic variants of herpes simplex virus show a conformationally complex epitope on glycoprotein H. J Virol 65: 2 393–2 401
Griffith BP, McCormick SR, Fong CKY, Lavallee JT, Lucia HL, Goff E (1985) The placenta as a site of cytomegalovirus infection in guinea pigs. J Virol 55: 402–409
Griffith BP, Aquino-De Jesus MJC (1991) Guinea pig model of congenital cytomegalovirus infection. Transplant Proc 23: 29–31
Imagawa M, Chiu R, Karin M (1987) Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell 51: 251–260
Jennes L, Stumpf WE (1983) Preparation and use of specific antibodies for immunohisto-chemistry of neuropeptides. Methods Enzymol 103: 448–459
Kaye JF, Gompels UA, Minson AC (1992) Glycoprotein H of human cytomegalovirus (HCMV) forms a stable complex with the HCMV UL115 gene product. J Gen Virol 73: 2 693–2 698
Kouzarides T, Bankier AT, Satchwell SS, Weston K, Tomlinson P, Barrell BG (1987) Sequence and transcription analysis of the human cytomegalovirus DNA polymerase gene. J Virol 61: 125–133
Kozak M (1984) Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acids Res 12: 857–872
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685
Landini MP, Re MC, Mirolo G, Baldassarri B, La Placa M (1985) Human immune response to cytomegalovirus structural polypeptides studied by immunoblotting. J Med Virol 17: 303–311
Li L, Coelingh KL, Britt WJ (1995) Human cytomegalovirus neutralizing antibody-resistant phenotype is associated with reduced expression of glycoprotein H. J Virol 69: 6 047–6 053
Maniatis T, Fritsch EF, Sambrook J (1982) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, New York
McLauchlan J, Gaffney D, Whitton JL, Clements JB (1985) The consensus sequence YGTGTTYY located downstream from the AATAAA signal is required for efficient formation of mRNA 3' termini. Nucleic Acids Res 13: 1 347–1 368
Pachl C, Probert WS, Hermsen KM, Masiarz FR, Rasmussen L, Merigan TC, Spaete RR (1989) The human cytomegalovirus strain Towne glycoprotein H gene encodes glycoprotein p86. Virology 169: 418–426
Plotkin SA, Starr SE, Friedman HM, Brayman K, Harris S, Jackson S, Tustin NB, Grossman R, Dafoe D, Barker C (1991) Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. Ann Intern Med 114: 525–531
Plotkin SA, Starr SE, Friedman HM, Gonczol E, Brayman K (1990) Vaccines for the prevention of human cytomegalovirus infection. Rev Infect Dis 12 [Suppl 7]: S827-S838
Porath A, McNutt RA, Smiley LM, Weigle KA (1990) Effectiveness and cost benefit of a proposed live cytomegalovirus vaccine in the prevention of congenital disease. Rev Infect Dis 12: 31–40
Rapp M, Messerle M, Lucin P, Koszinowski UH (1993)In vivo protection studies with mCMV glycoproteins gB and gH expressed by vaccinia virus. In: Michelson S, Plotkin SA (eds) Multidisciplinary approach to understanding cytomegalovirus disease. Elsevier, Amsterdam, pp 327–332
Rapp M, Lucin P, Messerle M, Loh LC, Koszinowski UH (1994) Expression of the murine cytomegalovirus glycoprotein H by recombinant vaccinia virus. J Gen Virol 75: 183–188
Rasmussen LE, Nelson RM, Kelsall DC, Merigan TC (1984) Murine monoclonal antibody to a single protein neutralizes the infectivity of human cytomegalovirus. Proc Natl Acad Sci USA 81: 876–880
Rasmussen L, Matkin C, Spaete R, Pachl C, Merigan TC (1991) Antibody response to human cytomegalovirus glycoproteins gB and gH after natural infection in humans. J Infect Dis 164: 835–842
Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 74: 5463–5467
Schleiss MR (1994) Cloning and characterization of the guinea pig cytomegalovirus glycoprotein B gene. Virology 202: 173–185
Schleiss MR (1995) Sequence and transcriptional analysis of the guinea-pig cytomegalovirus DNA polymerase gene. J Gen Virol 76: 1827–1833
Spaete RR, Perot K, Scott PI, Nelson JA, Stinski MF, Pachl C (1993) Coexpression of truncated human cytomegalovirus gH with the UL115 gene product or the truncated human fibroblast growth factor receptor results in transport of gH to the cell surface. Virology 193: 853–861
Spector DH, Klucher KM, Rabert DK, Wright DA (1990) Human cytomegalovirus early gene expression. Curr Top Microbiol Immunol 154: 21–45
Sturzl M, Roth WK (1990) “Run-off” synthesis and application of defined single-stranded DNA hybridization probes. Anal Biochem 185: 164–169
Von Heijne G (1986) A new method for predicting signal sequence cleavage sites. Nucleic Acids Res 14: 4683–4690
Xu J, Dallas PB, Lyons PA, Shellam GR, Scalzo AA (1992) Identification of the glycoprotein H gene of murine cytomegalovirus. J Gen Virol 73: 1849–1854
Yin C-Y, Gao M, Isom HC (1990) Guinea pig cytomegalovirus immediate-early transcription. J Virol 64: 1537–1548
Author information
Authors and Affiliations
Additional information
The nucleotide sequences reported in this paper have been submitted to the GenBank database and assigned the accession number U49361.
Rights and permissions
About this article
Cite this article
Brady, R.C., Schleiss, M.R. Identification and characterization of the guinea-pig cytomegalovirus glycoprotein H gene. Archives of Virology 141, 2409–2424 (1996). https://doi.org/10.1007/BF01718640
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01718640